Akèy › Kansè pwostat
Etid klinik pou Kansè pwostat ap rekrite nan Etazini
486 etid pou Kansè pwostat ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY103 etid
- Houston, TX76 etid
- Los Angeles, CA61 etid
- Boston, MA60 etid
- St. Louis, MO47 etid
- San Francisco, CA45 etid
- Chicago, IL45 etid
- Philadelphia, PA44 etid
- Seattle, WA44 etid
- Nashville, TN43 etid
- Baltimore, MD42 etid
- Washington, DC38 etid
- Dallas, TX36 etid
- Cleveland, OH34 etid
- Portland, OR33 etid
- Durham, NC32 etid
- Atlanta, GA32 etid
- Baldwin Park, CA31 etid
- San Diego, CA30 etid
- Edison, NJ30 etid
- Madison, WI29 etid
- Omaha, NE28 etid
- San Antonio, TX28 etid
- Queens, NY27 etid
- Ann Arbor, MI27 etid
- Miami, FL27 etid
- Jacksonville, FL26 etid
- Columbus, OH24 etid
- Myrtle Beach, SC23 etid
- Minneapolis, MN23 etid
- Pittsburgh, PA23 etid
- Detroit, MI23 etid
- Rochester, MN22 etid
- New Haven, CT21 etid
- Oklahoma City, OK21 etid
- Milwaukee, WI20 etid
- Grand Rapids, MI19 etid
- Denver, CO19 etid
- Richmond, VA19 etid
- Sacramento, CA19 etid
Pa eta
- Alabama12 etid
- Alaska5 etid
- Arizona42 etid
- Arkansas12 etid
- Ayiti5 etid
- Colorado40 etid
- Connecticut28 etid
- Delaware9 etid
- Distrik Columbia18 etid
- Florid101 etid
- Georgia41 etid
- Idaho12 etid
- Illinois64 etid
- Indiana24 etid
- Iowa16 etid
- Kalifòni157 etid
- Kansas22 etid
- Kentucky19 etid
- Lwizyàn23 etid
- Main4 etid
- Maryland64 etid
- Massachusetts67 etid
- Michigan57 etid
- Minnesota48 etid
- Mississippi7 etid
- Missouri48 etid
- Montana17 etid
- Nebraska28 etid
- Nevada8 etid
- New Hampshire7 etid
- New Jersey42 etid
- New Mexico10 etid
- New York126 etid
- North Carolina47 etid
- North Dakota8 etid
- Ohio65 etid
- Oklahoma24 etid
- Oregon38 etid
- Pennsylvania64 etid
- Rhode Island9 etid
- South Carolina43 etid
- South Dakota7 etid
- Tennessee50 etid
- Texas115 etid
- Utah25 etid
- Vermont5 etid
- Virginia54 etid
- Washington53 etid
- West Virginia6 etid
- Wisconsin47 etid
- Wyoming5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
Ap rekriteFaz 2
Laj 18 a 120 · Gason · Mizajou Oct 1, 2026 · NCT07686380PET/CT Characterization of Treatment Resistance
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Oct 1, 2026 · NCT05647564A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT04751435The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07285044Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382Addressing Health Literacy With a Tailored Survivorship Care Plan
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 30, 2026 · NCT06674863Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 30, 2026 · NCT05534646Autonomic and Renal Contributions to Hypertension With ADT
Ap rekriteFaz 4Volontè an sante akeyi
Laj 40 ak plis · Gason · Mizajou Sep 30, 2026 · NCT07848828Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 29, 2026 · NCT01492972Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
Ap rekriteVolontè an sante akeyi
Laj 21 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT06541210Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Ap rekriteFaz 4
Laj 18 ak plis · Gason · Mizajou Sep 29, 2026 · NCT07569926Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
Ap rekriteFaz 2
Laj 19 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06738303An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
Ap rekriteFaz 2
Laj 18 a 90 · Gason · Mizajou Sep 29, 2026 · NCT07185165A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 28, 2026 · NCT06095089Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 28, 2026 · NCT06496256Collection of Blood From Patients With Cancer
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT00034216Precision-Based Genomics in Prostate Cancer
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Gason · Mizajou Sep 28, 2026 · NCT04706663Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Ap rekriteEtid obsèvasyon
Laj 3 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT01441089Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Ap rekriteEtid obsèvasyon
Laj 40 a 75 · Gason · Mizajou Sep 28, 2026 · NCT07543757Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Ap rekriteFaz 1/2
Laj 18 a 130 · Gason · Mizajou Sep 25, 2026 · NCT07181161Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06759701A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07832292A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07746713Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07377006Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.